Scynexis Inc
Scynexis Inc (SCYX) Option Chain
As of September 25, 2026, Scynexis Inc is trading at $4.39, a -1.35% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 149.0%. IV Rank is 53%.
Read more
Tracking the SCYX option chain helps you see every strike and expiry on Scynexis Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Scynexis Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of SCYX options activity at a glance. Use our scanner to monitor the SCYX option chain in real time and filter for the SCYX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For SCYX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the SCYX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where SCYX stock options are being actively traded and where they are not.
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp.
The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Scynexis Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen SCYX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of SCYX stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV percentile60.71% Neutral
- Market cap (M$)44
- 52 weeks high-51.86%
- 52 weeks low24.36%
- Analyst recommendationStrong Buy
1.00 - Target price$36.55
732.57% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E—
- EPS (ttm)-1.84
- EPS growth next 5 years-15.40%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 7.86 | 0 | 0 | 3.01 | 1.89 | — | 4.90 | 2.50 | -43.05 | — | 0.05 | 0.00 | 0.05 | 0 | 90 | 92.14 |
| 70.45 | 126 | 8 | 0.28 | 0.00 | 0.10 | 0.45 | 5.00 | +13.90 | — | 1.40 | 0.61 | 0.79 | 0 | 12 | 29.55 |
| 95.35 | 125 | 0 | 0.15 | 0.00 | — | 0.15 | 7.50 | +70.84 | 0.70 | 5.50 | 3.11 | -0.01 | 0 | 0 | 4.65 |
| 99.36 | 0 | 0 | 4.60 | 0.00 | — | 4.60 | 10.00 | +127.79 | 3.00 | 8.00 | 5.61 | -0.11 | 0 | 0 | 0.64 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full SCYX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→